Clinical Trial Update: Exploratory Clinical Study on the Safety and Efficacy of CD19X CAR-T Cell Injection in the Treatment of Relapsed/Refractory Large B-Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

An exploratory Phase 1/2 clinical trial update evaluating the safety and efficacy of CD19X CAR-T cell injections for relapsed/refractory large B-cell lymphoma, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Large B-cell Lymphoma

Drugs mentioned

• CD19X CAR-T Cell Injection (CD19X CAR-T cell therapy)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Large B-Cell Lymphoma (LBCL) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING